Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Biomarker Testing Market Valued at Present and by 2029?

In the past few years, the size of the biomarker testing market has substantially increased. It is projected to escalate from $17.51 billion in 2024 to $19.75 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.8%. The historical rise can be credited to variables such as the widespread acceptance of personalized medication, the prevalent application of biomarkers in the field of oncology, the increasing prevalence of persistent ailments, expanded funding in life sciences research, and the escalating demand for early detection of diseases.

The market size of biomarker testing is predicted to experience substantial expansion in the imminent years, escalating to $31.63 billion in 2029 with a compound annual growth rate (CAGR) of 12.5%. This anticipated surge in the forecast period can be linked to the increasing use of biomarkers in non-cancerous diseases, escalation in investments toward companion diagnostics, advancements in the integration of artificial intelligence in diagnostics, widening application of point-of-care testing, and a growing understanding of preventive healthcare. Notable trends expected during the forecast period are improvements in sequencing technologies, unceasing innovations in liquid biopsy, progression in multiplex biomarker platforms, breakthroughs in proteomics and metabolomics, and financial influx in research and development.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24480&type=smp

#What Drivers Are Influencing Growth In The Biomarker Testing Market?

The escalating burden of cancer is projected to drive the expansion of the biomarker testing market. Cancer is a collective term for diseases characterized by the uncontrolled proliferation and dissemination of abnormal cells within the body. This increase in cancer cases can be traced back to certain lifestyle choices like unhealthy dietary habits, smoking, sedentary lifestyle, and excess alcohol intake. Biomarker testing offers enhanced cancer detection by facilitating early and accurate identification of disease-specific markers, hence improving the precision of diagnosis. Such testing aids in formulating personalized treatment strategies, thus yielding superior patient results and fostering efficient healthcare management. For example, the Australian Institute of Health and Welfare, a government agency based in Australia, reported that the number of diagnosed cancer cases in Australia reached 160,570 in 2022, up by 3,789 cases from 156,781 recorded in 2021. As a result, the mounting cancer burden is fueling the growth of the biomarker testing market.

What Are The Main Segments Identified In The Biomarker Testing Market Research?

The biomarker testing market covered in this report is segmented –

1) By Product Type: Consumables, Instruments, Services

2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, Immunoassays, Other Technologies

3) By Application: Oncology, Cardiology, Neurology, Infectious Diseases, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Consumables: Reagents, Assay Kits, Sample Collection Devices, Chemicals And Buffers

2) By Instruments: Polymerase Chain Reaction (PCR) Systems, Next-Generation Sequencing (NGS) Platforms, Microarray Systems, Mass Spectrometry Instruments, Immunoassay Analyzers

3) By Services: Biomarker Discovery Services, Diagnostic Testing Services, Companion Diagnostic Development, Clinical Trial Testing Services, Contract Research Organization (CRO) Services

What Are The Leading Trends And Opportunities In The Biomarker Testing Sector?

Leading firms in the biomarker testing market are prioritizing the creation of advanced technology solutions like immunohistochemistry (IHC) technology. These advancements aim to enhance diagnostic precision, facilitate early detection of diseases, and support tailored treatment approaches. IHC technology is a lab method that uses antibodies to spot specific proteins in tissue samples, a key tool in identifying and visualizing disease biomarkers for diagnosis and study. For example, in July 2023, US-based medical laboratories corporation, Quest Diagnostics Incorporated, rolled out a new tissue-based prostate cancer biomarker test via its AmeriPath entity. This leverages proprietary biomarkers EV1, EV2, and EV3 to augment diagnostic precision. The test plays a pivotal role in doctors’ ability to accurately identify and distinguish severe prostate cancer types, consequently improving grading consistency and informing suitable treatment plans for patients.

Which Companies Play A Key Role In The Development Of The Biomarker Testing Market?

Major companies operating in the biomarker testing market are Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Hologic Inc., Charles River Laboratories International Inc., PerkinElmer Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Myriad Genetics Inc., Guardant Health Inc., Sino Biological Inc., Proteome Sciences plc

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/biomarker-testing-global-market-report

What Are The Key Regional Developments Shaping The Biomarker Testing Market?

North America was the largest region in the biomarker testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24480&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model